reports
CardioComm Solutions Completes Issuance of Shares for Debt
Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company's press releases dated April 27, 2021 and April 8, 2021 for further details). Under debt settlement agreements, the Company has issued an aggregate of 3,353,644 common shares of the Company ("Shares") to directors, employees and consultants of the Company to s...
CardioComm Solutions to Issue Shares for Debt and Issue Stock Options
Toronto, Ontario--(Newsfile Corp. - April 27, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced the proposed issuance of shares for debt and the issuance of stock options. Under debt settlement agreements, the Company will issue an aggregate of 2,947,394 common shares of the Company ("Shares") to a director, employees and consultants of the Company at a deemed price of $0.055 per Share. The Shares will be provided to settle debt for services p...
CardioComm Solutions to Issue Shares for Debt and Issue Stock Options
Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced the proposed issuance of shares and the issuance of stock options.Under shares for debt agreements, the Company will issue an aggregate of 406,250 common shares of the Company ("Shares") to directors of the Company at a deemed price of $0.06 per Share. The Shares will be provided to settle debt for service expenses and will be subject to a four month...
CardioComm Solutions Expands ISO Clearance to Include Multiple Biosign...
New ISO 13485:2016 MDSAP scope paves the way to integration of novel and multiple bio sign monitoring devices for broader patient monitoring solution sales to the consumer and Rx markets globallyToronto, Ontario--(Newsfile Corp. - February 9, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received approval on an expanded ISO 13485:2016 ("ISO") certification in compliance with the Medical Device Single Audit Program ("MDSAP") fo...
CardioComm Solutions Provides Financial Update
Toronto, Ontario--(Newsfile Corp. - January 10, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is confirming the appointment of a new Chief Financial Officer and completion of a debt to equity settlement.On December 29, 2020, the Company announced that two of its four lenders had exercised their right to convert loans that had been recently renewed under a two year term, to equity. With the approval of the TSX-V, CardioComm confirms the issuance of ...
CardioComm Collaborates with ZANA Technologies GmbH to Integrate Mobil...
ECG technologies to be tested within ZANA's remote patient monitoring platform in 2020Toronto, Ontario--(Newsfile Corp. - December 3, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company" or "CCS"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, and Karlsruhe, Germany-based start-up ZANA Technologies GmbH ("ZANA") confirm entering into a business collaboration where CardioComm's GEMS™ ECG reviewing and HeartCheck™ ECG monitoring technologies are being evaluated to support ZANA's novel, voice-di...
CardioComm Solutions Secures New Health Canada Device Clearance and Ex...
Device certification to meet underserviced Canadian market needs for long-term, remote ECG recording and ECG management software solutions.Toronto, Ontario--(Newsfile Corp. - October 28, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, today announced it has entered into an exclusive sales and marketing agreement for the GEMS™ Sirona with California-based Datrix LLC ("Datrix").Under the multi-year, renewable agreement, CardioComm assumes the...
CardioComm Solutions Secures Newest US and Canadian Medical Device 134...
MDSAP Certification to Expand Market Access for CardioComm's Medical Devices and SoftwareToronto, Ontario--(Newsfile Corp. - October 21, 2019) - - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has completed its ISO 13485:2016 ("ISO") certification in compliance with the Medical Device Single Audit Program ("MDSAP"), a mandatory requiment under Health Canada and accepted as an equivalent quality management certification by the USA Food and Drug A...
CardioComm Solutions Issues Shares for Services
Toronto, Ontario--(Newsfile Corp. - October 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces shares and options.Under an online marketing and awareness program agreement with AGORA Internet Relations Corp. ("AGORACOM") the Company has issued to AGORACOM 226,000 common shares of the Company ("Shares"), representing a price of $0.05 per Share, for services valued at $10,000 plus 13% HST. The Company also issued 62,500 stock options to Eti...
CardioComm Solutions Issues Shares for Services
Toronto, Ontario--(Newsfile Corp. - September 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its fourth issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press releases dated November 8, 2018 and December 13, 2018.Under this fourth share issuance, the Company will issue 226,...
CardioComm Solutions Issues Shares for Services and Debt
Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces shares and options.Under an online marketing and awareness program agreement with AGORA Internet Relations Corp. ("AGORACOM") the Company has issued to AGORACOM 188,333 common shares of the Company ("Shares"), representing a price of $0.06 per Share, for services valued at $10,000 plus 13% HST. Under shares for debt agreements, the Company has issued ...
CardioComm Solutions to Issue Shares for Services and Debt
Toronto, Ontario--(Newsfile Corp. - June 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) (OTC PINK: EKGGF) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its third issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press releases dated November 8, 2018 and December 13, 2018. Under this third share issuance to AGORACOM, th...
CardioComm Solutions Announces ECG Services Integration and Co-Marketi...
Integration of GEMS(TM) Universal ECG App with BodiMetrics hardware platform expands ECG Device Manufacturer's Offerings to now Include Credible ECG Reporting ServicesToronto, Ontario--(Newsfile Corp. - May 15, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces the execution of an ECG and multiple biosign monitoring device integration and co-marketing agreement with California-based BodiMetrics LLC ("BodiMetrics"). With the launch of...
CardioComm Solutions GEMS(TM) Universal ECG App Launched in Partnershi...
Health Canada and FDA Approved GEMS Mobile ECG App Expands Credible ECG Reporting Services Across Global MarketsToronto, Ontario--(Newsfile Corp. - May 14, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced today that its GEMS™ Universal ECG app ("GEMS™ Universal"), a version of the Company's US Food and Drug Administration ("FDA") cleared and Health Canada approved GEMS™ Mobile ECG app, is now available for download from the Google...
CardioComm Solutions' Heartcheck(TM) CardiBeat Handheld ECG Device Cle...
The Bluetooth HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Smartphone App will Target Home, Outpatient, Telemedicine and Cardiac Arrhythmia Monitoring MarketsToronto, Ontario--(Newsfile Corp. - May 9, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received approval from Health Canada for the over-the-counter ("OTC") sales and marketing of its existing GEMS™ Mobile smartphone app and for the HeartCheck™ CardiBeat, its newest handheld he...
CardioComm Solutions Provides Financing Update
Toronto, Ontario--(Newsfile Corp. - April 12, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms that it has repaid $100,000 in outstanding loans and that the remaining $500,000 in loans, which would have otherwise matured on March 31, 2019, have been extended by the lenders.The maturing loans were made by four lenders to the Company in December 2016, as described in the Company's press release dated December 21, 2016, and were extended in Dece...
CardioComm Solutions Files with Health Canada for Direct to Consumer S...
Bluetooth Connected HeartCheck CardiBeat and GEMS Mobile Smartphone App to Target Underserviced Canadian Home and Telemedicine Arrhythmia Monitoring MarketsToronto, Ontario--(Newsfile Corp. - April 9, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has filed with Health Canada for approval for the over-the-counter ("OTC") sales and marketing of their GEMS™ Mobile smartphone app and their newest handheld, heart rhythm monitor, the HeartChec...
CardioComm Solutions to Issue Shares Under Online Marketing and Awaren...
Awareness program to expand distribution of Company's updates to retail and institutional investorsToronto, Ontario--(Newsfile Corp. - April 6, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has made its second issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company initially announced the online marketing and awareness program in its press releases dated Nove...
CardioComm Solutions to Issue Shares Under Online Marketing and Awaren...
Awareness program to expand distribution of Company's updates to retail and institutional investorsToronto, Ontario--(Newsfile Corp. - April 2, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its second issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press releases dated Novemb...
CardioComm Solutions Issues Stock Options
Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five years from the date of grant and vest immediately. The grants are subject to the provisions of the Company's Stock Option Plan, the policies of the TSX Venture Exchange and ap...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.